213 related articles for article (PubMed ID: 17907149)
1. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients.
Manetti M; Neumann E; Milia AF; Tarner IH; Bechi P; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2007 Oct; 56(10):3442-7. PubMed ID: 17907149
[TBL] [Abstract][Full Text] [Related]
2. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis.
Manetti M; Rosa I; Messerini L; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L
J Cell Mol Med; 2014 Feb; 18(2):253-62. PubMed ID: 24467430
[TBL] [Abstract][Full Text] [Related]
3. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
Ikawa Y; Ng PS; Endo K; Kondo M; Chujo S; Ishida W; Shirasaki F; Fujimoto M; Takehara K
J Cell Physiol; 2008 Sep; 216(3):680-7. PubMed ID: 18481257
[TBL] [Abstract][Full Text] [Related]
6. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.
Cipriani P; Di Benedetto P; Ruscitti P; Verzella D; Fischietti M; Zazzeroni F; Liakouli V; Carubbi F; Berardicurti O; Alesse E; Giacomelli R
Arthritis Res Ther; 2015 Sep; 17(1):247. PubMed ID: 26357964
[TBL] [Abstract][Full Text] [Related]
7. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma.
Leask A
Cell Signal; 2008 Aug; 20(8):1409-14. PubMed ID: 18296024
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.
Mendoza FA; Piera-Velazquez S; Farber JL; Feghali-Bostwick C; Jiménez SA
Arthritis Rheumatol; 2016 Jan; 68(1):210-7. PubMed ID: 26360820
[TBL] [Abstract][Full Text] [Related]
9. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.
Nicola S; Rolla G; Bucca C; Geronazzo G; Ridolfi I; Ferraris A; Fusaro E; Peroni CL; Dughera L; Brussino L
Cells; 2020 Sep; 9(9):. PubMed ID: 32947843
[TBL] [Abstract][Full Text] [Related]
10. The gastric wall in systemic sclerosis patients: a morphological study.
Manetti M; Milia AF; Benelli G; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L
Ital J Anat Embryol; 2010; 115(1-2):115-21. PubMed ID: 21073000
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
[TBL] [Abstract][Full Text] [Related]
15. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.
Holmes A; Abraham DJ; Chen Y; Denton C; Shi-wen X; Black CM; Leask A
J Biol Chem; 2003 Oct; 278(43):41728-33. PubMed ID: 12888575
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro.
Zhang C; Meng X; Zhu Z; Liu J; Deng A
Cell Biol Int; 2004; 28(12):863-73. PubMed ID: 15566956
[TBL] [Abstract][Full Text] [Related]
17. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
[TBL] [Abstract][Full Text] [Related]
19. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
